End-to-End Deal Structuring : Guide clients through the negotiation of licensing, joint development, and R&D collaboration agreements.

IP & Patent Strategy Alignment : Ensure intellectual property portfolios are leveraged effectively within the scope of the transfer.

Regulatory-Sensitive Terms : Integrate clauses aligned with FDA/EMA compliance, clinical trial stages, and approval timelines.

Valuation of Pharma IP : Support fair market valuation of molecules, formulations, and associated research data.

Risk Mitigation Planning : Draft terms to manage clinical, technical, and commercial risks in the development pipeline.

Revenue & Royalty Frameworks : Design tiered royalty, milestone, and profit-sharing models tailored to the deal structure.

Cross-Border Negotiation Expertise : Facilitate negotiations involving international partners, IP jurisdictions, and regulatory bodies.

The post Pharma R&D Transfer Negotiation – Consult an Expert appeared first on SUKISH GROUP.